BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31621421)

  • 1. Is the incidence of motor neuron disease higher in French military personnel?
    Vlaar T; Elbaz A; Moisan F
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):107-115. PubMed ID: 31621421
    [No Abstract]   [Full Text] [Related]  

  • 2. [Retrospective study of ALS in French military personnel].
    Drouet A; Desjeux G; Balaire C; Thevenin-Garron V
    Rev Neurol (Paris); 2010; 166(6-7):621-9. PubMed ID: 20206953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Farming and incidence of motor neuron disease: French nationwide study.
    Kab S; Moisan F; Elbaz A
    Eur J Neurol; 2017 Sep; 24(9):1191-1195. PubMed ID: 28727213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nationwide incidence of motor neuron disease using the French health insurance information system database.
    Kab S; Moisan F; Preux PM; Marin B; Elbaz A
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Aug; 18(5-6):426-433. PubMed ID: 28387141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.
    Conde B; Winck JC; Azevedo LF
    Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of amyotrophic lateral sclerosis and other motor neuron disease among men with benign prostatic hyperplasia: a population-based cohort study.
    Sørensen TT; Horváth-Puhó E; Nørgaard M; Ehrenstein V; Henderson VW
    BMJ Open; 2019 Jul; 9(7):e030015. PubMed ID: 31278107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological characteristics of motor neuron disease in Chinese patients.
    Cui F; Liu M; Chen Y; Huang X; Cui L; Fan D; Pu C; Lu J; Zhou D; Zhang C; Yan C; Li C; Ding X; Liu Y; Li X; Jiang Y; Zhang J; Shang H; Yao X; Ding Y; Niu Q; Wang L
    Acta Neurol Scand; 2014 Aug; 130(2):111-7. PubMed ID: 24689740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiology of motor neurone disease in two counties in the southwest of England.
    Imam I; Ball S; Wright D; Hanemann CO; Zajicek J
    J Neurol; 2010 Jun; 257(6):977-81. PubMed ID: 20094727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent sex ratios of motor neuron disease: French nationwide study and meta-analysis.
    Ahmadzai P; Kab S; Vlaar T; Artaud F; Carcaillon-Bentata L; Canonico M; Moisan F; Elbaz A
    Neurology; 2018 May; 90(18):e1588-e1595. PubMed ID: 29602909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence and prevalence of motor neurone disease in South Australia.
    Luker J; Woodman R; Schultz D
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):195-202. PubMed ID: 35934980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study.
    Alonso A; Logroscino G; Jick SS; Hernán MA
    Eur J Neurol; 2009 Jun; 16(6):745-51. PubMed ID: 19475756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology.
    Beard JD; Engel LS; Richardson DB; Gammon MD; Baird C; Umbach DM; Allen KD; Stanwyck CL; Keller J; Sandler DP; Schmidt S; Kamel F
    Environ Int; 2016 May; 91():104-15. PubMed ID: 26923711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and survival trends of motor neurone disease in Northern Ireland from 2015 to 2019.
    McCluskey G; Duddy W; Haffey S; Morrison K; Donaghy C; Duguez S
    Eur J Neurol; 2022 Mar; 29(3):707-714. PubMed ID: 34748676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of incidence of motor neuron disease in England 1998-2019: use of three linked datasets.
    Burchardt JM; Mei XW; Ranger T; McDermott CJ; Radunovic A; Coupland C; Hippisley-Cox J
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug; 23(5-6):363-371. PubMed ID: 35103515
    [No Abstract]   [Full Text] [Related]  

  • 15. Epidemiology of motor neuron disease in the Kii Peninsula of Japan, 1989-1993: active or disappearing focus?
    Yoshida S; Uebayashi Y; Kihira T; Kohmoto J; Wakayama I; Taguchi S; Yase Y
    J Neurol Sci; 1998 Mar; 155(2):146-55. PubMed ID: 9562259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of and risk factors for motor neurone disease in UK women: a prospective study.
    Doyle P; Brown A; Beral V; Reeves G; Green J
    BMC Neurol; 2012 May; 12():25. PubMed ID: 22559076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of amyotrophic lateral sclerosis.
    Kurtzke JF
    Adv Neurol; 1982; 36():281-302. PubMed ID: 6983824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology and survival.
    Beard JD; Kamel F
    Epidemiol Rev; 2015; 37(1):55-70. PubMed ID: 25365170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of motor nueron disease in Scotland.
    Forbes RB; Colville S; Parratt J; Swingler RJ
    J Neurol; 2007 Jul; 254(7):866-9. PubMed ID: 17420925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989.
    J Neurol Neurosurg Psychiatry; 1992 Jul; 55(7):536-41. PubMed ID: 1640227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.